首页> 美国卫生研究院文献>Oncotarget >Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling
【2h】

Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling

机译:靶向VEGF-C / VEGFR3轴可通过抑制KRAS / YAP1信号传导来抑制Slug介导的癌症转移和癌变。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Vascular endothelial growth factor-C (VEGF-C) has been implicated in epithelial-mesenchymal transition (EMT) processes and various human cancers, including skin cancer. Skin cancer is an aggressive human malignancy with increasing incidence worldwide; however, the underlying mechanisms involved in VEGF-C-induced skin cancer stemness and metastasis remain unclear. Here, we report that VEGF-C enhances skin cancer migration, invasion and stemness through Slug up-regulation. Oncomine database analysis indicated that the KRAS/MAPK (mitogen-activated protein kinases) pathway and YAP1 (yes-associated protein 1) expression are positively correlated with metastatic skin cancer. We show that VEGF-C triggers the activation of KRAS/MAPK signaling to increase YAP1 and downstream Slug expression, which are suppressed by an anti-VEGFR3 (VEGF receptor 3) peptide, a specific peptide targeting VEGFR3. The VEGF-C-induced migration, invasion and stemness of skin cancer cells are also abrogated by the anti-VEGFR3 peptide. Based on these data, we reveal the role of the VEGF-C/VEGFR3-mediated KRAS/MAPK-YAP1/Slug pathway in skin cancer progression and propose that the VEGF-C/VEGFR3 axis is a promising target for the anti-VEGFR3 peptide.
机译:血管内皮生长因子-C(VEGF-C)与上皮-间质转化(EMT)过程以及包括皮肤癌在内的各种人类癌症有关。皮肤癌是一种侵袭性的人类恶性肿瘤,在全球范围内发病率不断上升。然而,涉及VEGF-C诱导的皮肤癌干和转移的潜在机制仍不清楚。在这里,我们报道VEGF-C通过Slug上调增强皮肤癌的迁移,侵袭和干性。 Oncomine数据库分析表明,KRAS / MAPK(促分裂原活化蛋白激酶)途径和YAP1(是相关蛋白1)表达与转移性皮肤癌呈正相关。我们显示,VEGF-C触发KRAS / MAPK信号的激活,以增加YAP1和下游Slug表达,这被抗VEGFR3(VEGF受体3)肽(一种靶向VEGFR3的特异性肽)抑制。 VEGF-C诱导的皮肤癌细胞迁移,侵袭和干性也被抗VEGFR3肽所消除。基于这些数据,我们揭示了VEGF-C / VEGFR3介导的KRAS / MAPK-YAP1 / Slug途径在皮肤癌进展中的作用,并提出VEGF-C / VEGFR3轴是抗VEGFR3肽的有希望的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号